There’s a lot going on. Here are today’s COVID-19 updates that you should know.
Your daily dose of hope
Widespread antibody testing is considered to be a crucial component when it comes to the process of restarting the economy and identifying who can safely return to work.
As antibody testing becomes more readily available, so too does the likelihood of helping COVID-19 patients recover. Microsoft is launching a self-screening tool so people can see whether or not they qualify to donate their plasma in the hopes of creating a treatment for those with the coronavirus.
Elective surgeries are slowing re-emerging throughout the country, a sign that hospitals are feeling safe enough to go ahead with other procedures.
They’re good dogs, Brent.
News you need to know
Remdesivir didn’t perform as hoped, proving unsuccessful in the first trial of the drug that many hoped would help in treatment of COVID-19.
Medical experts and CPG professionals find themselves thrust in the midst of an educational spotlight after President Trump suggested that “injecting” disinfectants into the body or using ultraviolet light could be used to kill the coronavirus.
States continue to struggle to get the funds that are desperately needed into the hands of their citizens, as technology, too, cracks under the weight of COVID-19.
https://twitter.com/JK4Florida/status/1253703590004379648?s=20
Governors and state officials are still clamoring for PPEs and testing kits, months after the virus arrived in the states. The efforts that they are going to in order to acquire these precious goods is turning supply chain management upside-down.
Quote of the day:
“What you can’t bury give away / what you can’t give away you must carry with you, / it is always heavier than you thought. – Margaret Atwood
Data of the day
Find more infographics at Statista
